Iht Wealth Management, LLC Halozyme Therapeutics, Inc. Transaction History

Iht Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 18, 2021	SELL	$39.51 - $51.45 $243,776 - $317,446	-6,170 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$25.81 - $43.62 $159,247 - $269,135	6,170 New	6,170 $264,000
Q2 2018 Aug 13, 2018	SELL	$16.87 - $20.3 $3,374 - $4,060	-200 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$16.75 - $20.8 $3,350 - $4,160	200	200 $4,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.